FindTrial
Sign In

Influencing Factors Involved in Stent Replacement for Cholangiolithiasis after Endoscopic Retrograde Biliary Drainage: A Case-Control Study

Influencing Factors Involved in Stent Replacement for Cholangiolithiasis after Endoscopic Retrograde Biliary Drainage: A Case-Control Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094946
Enrollment
Unknown
Registered
2024-12-30
Start date
2024-12-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiolithiasis

Interventions

Stent replacement:None
Stent removal:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with bile duct stones treated with ERCP between January 2018 and December 2023. Indications include confirmed bile duct stones, obstructive jaundice, biliary pancreatitis, and biliary stenting for strictures and leakage.

Exclusion criteria

Exclusion criteria: 1.Those who have not undergone endoscopy; 2.Patients undergoing endoscopic therapy but not ERBD; 3.Patients with bile duct cancer; 4.Patients with malignant biliary stricture or obstruction; 5.Patients with peribile duct tumors involving the liver, pancreas or duodenum; 6.History of hepatobiliary surgery; 7.Patients with suspected malignant biliary tract tumors found during surgery; 8.Incomplete medical history; 9.Failed ERCP or ERBD; 10.Loss to follow-up;

Design outcomes

Primary

MeasureTime frame
clinical manifestation;complication;bilirubin;Stent blockage;—

Countries

China

Contacts

Public ContactLi Baiwen

Shanghai General Hospital

249612702@qq.com+86 18930894343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026